HIV Policy & Advocacy
Supreme Court Rules Against Anti-Prostitution Pledge for HIV/AIDS Funding
- Details
- Category: HIV Policy & Advocacy
- Published on Friday, 21 June 2013 00:00
- Written by Liz Highleyman
The Supreme Court of the U.S. this week struck down a provision that requires agencies receiving global HIV/AIDS funding to affirm their opposition to prostitution, stating that it is an unconstitutional restriction of free speech.
UNAIDS, Advocates Publish HIV Criminalization Reports; Webinar June 25
- Details
- Category: HIV Policy & Advocacy
- Published on Friday, 21 June 2013 00:00
- Written by Liz Highleyman
UNAIDS last month released a report on ending overly broad criminalization of HIV exposure and non-intentional transmission, emphasizing that laws should reflect the latest science. International advocates released their own report on HIV criminalization in early June, and the HIV Prevention Justice Alliance (HIVPJA) will hold a webinar on Tuesday, June 25, to strategize about the REPEAL HIV Criminalization Act.
U.S. Preventive Services Task Force Recommends Routine HIV Screening for Adolescents and Adults
- Details
- Category: HIV Testing & Diagnosis
- Published on Friday, 03 May 2013 00:00
- Written by Liz Highleyman
On April 30 the U.S. Preventive Services Task Force (USPSTF) issued a "Grade A," or highest-level, recommendation that all adolescents and adults ages 15 through 65 years should receive routine HIV screening. "These recommendations...reinforce the importance of people everywhere knowing their HIV status and, if positive, accessing care, receiving treatment and other prevention services," said CDC's Jonathan Mermin.
Senate Approves Bill to Allow HIV+ Patients to Receive HIV+ Donor Organs
- Details
- Category: HIV Policy & Advocacy
- Published on Wednesday, 19 June 2013 00:00
- Written by Liz Highleyman
The U.S. Senate this week unanimously passed the HOPE Act, a bill that will make an exception to current law enabling people with HIV to receive organs for transplantation from another HIV positive individual. The measure now awaits approval from the House of Representatives.
CROI 2013: Second-line NRTI-sparing HIV Regimen Proves Equally Effective
- Details
- Category: HIV Treatment
- Published on Wednesday, 20 March 2013 00:00
- Written by Keith Alcorn
A second-line antiretroviral regimen of lopinavir/ritonavir (Kaletra or Aluvia) and raltegravir (Isentress) proved just as effective as a regimen containing lopinavir/ritonavir and 2 or 3 nucleoside or nucleotide analogs in large study conducted in Australia, Africa, Latin America, and Asia, researchers from Sydney’s Kirby Institute reported this week at the 20th Conference on Retroviruses and Opportunistic Infections (CROI 2013) in Atlanta.
More Articles...
- CROI 2013: Small Risk of Birth Defects Due to Efavirenz Confirmed in French Cohort
- CROI 2013: HIV+ People Less Likely to Use Aspirin to Prevent Heart Attacks, and May Benefit Less [VIDEO]
- CROI 2013: New Pro-drug Tenofovir Alafenamide Appears Equally Effective but Better Tolerated
- CROI 2013: Can People with Resistant HIV Omit NRTIs When Switching to a New Regimen? [VIDEO]
Web Design and Development by